SOURCES SOUGHT
65 -- OSTOMY SUPPLIES
- Notice Date
- 4/4/2007
- Notice Type
- Sources Sought
- Contracting Office
- Southeast Regional Contracting Office, ATTN: MCAA SE, Building 39706, Fort Gordon, GA 30905-5650
- ZIP Code
- 30905-5650
- Solicitation Number
- W91YTV-07-0007
- Response Due
- 4/27/2007
- Archive Date
- 6/26/2007
- Small Business Set-Aside
- N/A
- Description
- THIS IS A SOURCES SOUGHT NOTICE. FOR FURTHER INFORMATION CONTACT MS VIRGINIA (GINNY) SLAYTON AT 706-787-2019 OR Virginia.Slayton@us.army.mil Potential sources sought to participate in the regional standardization of Ostomy Supplies. A. General Information: Southeast Region (TRBO Reg 3&4), a military integrated delivery network, comprised of Army, Navy, Air Force, Marine Corps and Coast Guard medical treatment facilities (MTFs) in the states of states of Alabama, Georgia, Florida, Mississippi, South Caro lina, Tennessee, and affiliated areas of Puerto Rico, Honduras, and Cuba announces a Request for Regional Incentive Agreement Quotation (REFRIAQ) for the standardization of Ostomy Supplies. The primary objective of this standardization initiative is to achieve a best value determination that represents the clinically preferred product or source at the best possible price. It is also intended that standardized product be obtained through the DoD Prime Vendor Program. The major facilities in the area includes: MacDill AFB, FL, Eglin AFB, FL, Keesler AFB, MS, Fort Benning, GA, Fort Gordon, GA, Fort Stewart, GA, Fort Jackson, SC, Naval Hospital Jacksonville, FL, Naval Hospital Beaufort, SC, and Naval Hospital Pensacola, FL. This standardization action is part of the Medical/Surgical Prime Vendor Program executed by the Defense Supply Center Philadelphia, (DSCP) Directorate of Medical Materiel. In order to participate your company MUST have a Distribution and Pricing Agreemen t (DAPA) with the Defense Supply Center Philadelphia (DSCP) AND A separate commercial agreement with the Prime Vendors for the program. This is pursuant to the DAPA clause by which DAPA holders agree to the Standardization process and to allow Prime Vendo rs to distribute their items. This is a supplement to the Prime Vendor Program and it is NOT a contract. For additional information regarding DSCPs Prime Vendor program please access the web site at: https://dmmonline.dscp.dla.mil. The agreement with incentive pricing will be based on a committed volume for a base period of two (2) years (24 months) from the date of award with three (3) - 12 month option periods (not to exceed 5 years). A single selection is intended in this project ; however, the Southeast Region acknowledges the possibility of multiple selections for this agreement. Consideration will be based on best value to Government, based on evaluation of factors listed here. Anticipated award date is September 2007. The ev aluation will be based on clinical, technical, and pricing factors. The award will be determined utilizing Best Value/trade off criteria. Point of Contact is Ginny Slayton, (706) 787-2019, Virginia.slayton@us.army.mil. B. Products & Performance Required The Southeast Region is seeking product lines in the category of Ostomy Supplies. The yearly estimated total volume for Ostomy Supplies is $132,737.81. This is based on the historical prime vendor sales for a 12-month period. At the request of the Southeast Region Military Treatment Facilities vendors will provide on-site support and in-servicing, educational resources and tools for clinical use of the product, conversion information, prime vendor order numbers, MSDS informat ion, and itemization of the brand, types and packaging information of the products offered by the vendor. C. Instructions to Offerors DAPA holders interested in participating in this standardization initiative should email their (1) Company name and address, (2) Point of Contact (Name and phone number, fax, email address, and Solicitation Number) to Ginny Slayton, Virginia.slayton@us.arm y.mil (706) 787-2019 before 4:30 P.M. EDT on the date listed for closing on the FBO announcement in order to remain competitive. Vendors that fail to meet the submittal deadline will be disqualified. This process will include vendor requirements of electronic responses to technical/company crit eria, no charge samples for clinical evaluation, and submission of electronic best price offers. Due to the potential for email to be lost in transmission from network security, etc., vendors are strongly encouraged to confirm with the Southeast Region th at its initial submission, quote and literature actually arrived at the Region via email. Each submitting vendor is advised to confirm receipt, allowing adequate time for resubmission before 4:00 P.M. EST on the date listed for closing on the FBO announce ment in order to remain competitive. Vendors that fail to meet the re-submittal deadline will be disqualified. D. Evaluation Criteria The Tri-Service Product Review Board (TPRB) is the governing board of the standardization process. This board includes clinicians and logisticians from eight Military Treatment facilities in the Southeast Region. They are the final decision makers for this initiative. Phase I. Vendors will be required to the provide responses to the technical/company criteria. Vendors who do not meet the deadline for the solicitation response will be eliminated from the standardization process. The Clinical Product Team (CPT) compris ed of medical professionals from several disciplines will review the responses and determine acceptability. After review of technical/company criteria, those vendors who meet the criteria will be invited to participate in Phase II, the clinical/performanc e evaluation. Phase II. The TRBO will request product samples from the product group to be clinically evaluated at select Military Treatment Facilities. Vendors are required to ship samples direct to the MTFs. Vendors will be given 10 business days from the issue of the notice to ship samples. Vendors who do not send samples by 5:00 P.M. EST on the 10th business day will be disqualified from further consideration in the standardization process. Specific MTFs will evaluate the clinical/performance criteria using a Likert like one to five rating scale. One is equal to not acceptable and five is equal to highly acceptable. All clinical/performance questions weighted equally. The CPT has set a 3.0 acceptability threshold for all product groups. Clinical/performance results lower than a 3.0 will not be considered acceptable and will be disqualified from further consideration in the standardization process. Phase III. After the clinical/performance evaluation are completed and analyzed, all vendors in the clinical evaluation group who met the minimum 3.0 threshold will be invited to participate in Phase III, pricing evaluations. All vendors will be asked to submit their best pricing offer based on committed volume of 80% of the total requirements of the MTFs in the Southeast Region. Clinical/performance factors will be weighted more heavily than price. Pricing will be evaluated based on the best value to the government and will be based on a committed volume for a two-year period with possible one-year option periods (not to exc eed 5 years). Vendors that fail to offer an incentive discount from DAPA will be disqualified. 1. Technical/Company Criteria Evaluation In Phase I, the CPT will review the following technical/company criteria responses from each vendor and determine acceptability. Acceptability for purposes of evaluation of technical/company criteria: Generally responses to all questions in this section d emonstrate that: 1) the business concern offering the quote is a distributor or manufacturer of a complete line of the subject medical/surgical consumables; 2) based on the quoters responses, the evaluators have reasonable confidence that the line or prod ucts and/or services offered meet the medical standards of care of the community, applicable to such products or services; 3) the quoter has a DAPA for the items; 4) the quoter has an agreement covering the items, with Owens & Minor, the Prime Vendor for t he region; 5) the quoter intends to offer discounts off DAPA for all products included in this standardization initiative (vendors that fail to offer a discount from DAPA will be disqualified); and 6) the quoters information provided is factually correct (any misrepresentation of information will disqualify the vendor fro m further consideration.) a. Vendors must have a DAPA number for Ostomy Supplies. Provide DAPA number. b. Vendors must have separate agreement with Owens & Minor for distribution in the Southeast Region. Provide prime vendor conversion number. c. Vendors must provide all itemized brand(s) and styles that are manufactured and/or distributed for Ostomy Supplies. d. Vendors must provide the industry production and safety standards used in manufacturing this product. e. Vendors must identify if company has had history of back orders and/or recalls for the product line. Explaining the a) dates and duration b) cause, c) resolution. f. Vendors will provide company return goods policy & all warranties. g. Vendors will identify what kind of educational tools or materials you have for this product line. h. Vendors must identify what kind of staff training your company provides. i. Vendors must identify if company provides 24/7 customer service. j. Vendors must identify if products are latex free. k. Vendors must be able to provide and identify with response a full product line of Ostomy Supplies to include but not limited to: pre-cut &cut to fit wafer styles, one & two piece pouch options, a variety of sizes & styles of drainage pouches, variety of closure options for drainage bags and irrigation kits. l. Vendor must be able to provide and identify with response drainage pouch with odor proof systems. 2. Clinical/Performance Criteria Evaluation Phase II, a CPT comprised of medical professionals from several disciplines will evaluate the products based upon the following evaluation criteria to determine acceptability against the following criteria. a. Wafers are flexible and fit most contours. b. Wafers are compatible for irrigation. c. Drainage pouches open and close easily. d. Drainage pouches have secure attachments. e. Adhesive provides adequate adhesion to patients skin. f. Drainage pouch attaches easily to wafer and fit snugly. 3. Price Evaluation Technical/company (Phase I) and Clinical/performance (Phase II) factors will be evaluated first. The technical/company and clinical/performance evaluation will determine who the ac ceptable offerors are. Then the quotes (Phase III) will be compared regarding incentive price and the TPRB will perform a technical/price trade off (i.e., very superior technical capabilities may justify paying a higher price). THE CLOSING DATE IS 27 APR IL 2007 4:30 PM EDT.
- Place of Performance
- Address: Tri Service Southeast Regional Business Office ATTN: Building 40707 40th Street Room 105 Fort Gordon GA
- Zip Code: 30905-5650
- Country: US
- Zip Code: 30905-5650
- Record
- SN01266388-W 20070406/070404221207 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |